The DOI matches its Crossref record; 162 of the 163 references it cites were found in a registry or an index.
Biomarkers of neurodegeneration across the Global South
Open accessAbstract
Research on neurodegenerative diseases has predominantly focused on high-income countries in the Global North. This Series paper describes the state of biomarker evidence for neurodegeneration in the Global South, including Latin America, Africa, and countries in south, east, and southeast Asia. Latin America shows growth in fluid biomarker and neuroimaging research, with notable advancements in genetics. Research in Africa focuses on genetics and cognition but there is a paucity of data on fluid and neuroimaging biomarkers. South and east Asia, particularly India and China, has achieved substantial progress in plasma, neuroimaging, and genetic studies. However, all three regions face several challenges in the form of a lack of harmonisation, insufficient funding, and few comparative studies both within the Global South, and between the Global North and Global South. Other barriers include scarce infrastructure, lack of knowledge centralisation, genetic and cultural diversity, sociocultural stigmas, and restricted access to tools such as PET scans. However, the diverse ethnic, genetic, economic, and cultural backgrounds in the Global South present unique opportunities for bidirectional learning, underscoring the need for global collaboration to enhance the understanding of dementia and brain health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While extensively studied in high-income countries, resilience remains underexplored in the majority world, including low-, middleand upper-middle-income countries—where socioeconomic inequities, environmental stressors, large burdens of infectious and noncommunicable diseases and limited healthcare access shape unique health trajectories6–15.”
From Resilience and brain health in global populations (2025) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430 · cited 3×
“74 Brazilian studies successfully implemented the amyloid and [ 18 F]FDG-PET in the context of the 2018 NIA-Alzheimer’s Association research framework but highlighted clinical biomarker mismatches with sociodemographic effects.”
BackgroundMethodRetractedNichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575
Biomarker definitions and their applications
Califf, R. M. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217750088 · Cited by 1,528
Clock-drawing: is it the ideal cognitive screening test?
Shulman, K. I. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200006)15:6<515::aid-gps147>3.0.co;2-u · Cited by 1,385
The exposome and health: Where chemistry meets biology
Vermeulen, R., Schymanski, E. L., Barabási, A.-L., & Miller, G. W. (2020) · Science · doi:10.1126/science.aay3164 · Cited by 1,065
Analysis of polygenic risk score usage and performance in diverse human populations
Duncan, L., Shen, H., Gelaye, B., Meijsen, J., Ressler, K., Feldman, M., Peterson, R., & Domingue, B. (2019) · Nature Communications · doi:10.1038/s41467-019-11112-0 · Cited by 1,038
A roadmap to increase diversity in genomic studies
Fatumo, S., Chikowore, T., Choudhury, A., Ayub, M., Martin, A. R., & Kuchenbaecker, K. (2022) · Nature Medicine · doi:10.1038/s41591-021-01672-4 · Cited by 707
Reiman, E. M., Quiroz, Y. T., Fleisher, A. S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., Fagan, A. M., Shah, A. R., Alvarez, S., Arbelaez, A., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70228-4 · Cited by 541
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
Cho, H., Choi, J. Y., Hwang, M. S., Kim, Y. J., Lee, H. M., Lee, H. S., Lee, J. H., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2016) · Annals of Neurology · doi:10.1002/ana.24711 · Cited by 499
Self-citation
Research works printed but not linked: 2
- Sjahrir, 2001, The Mini Mental State Examination in healthy individuals in Medan, Indonesia by age and education level, Neurol J Seast Asia, 6, 19
- Miranda, 2017, Abnormal expansion of C9orf72 gene in familial frontotemporal dementia, Rev Med Chil, 145, 896
Cited by
Resilience and brain health in global populations
Udeh-Momoh, C. T., Migeot, J., Blackmon, K., Mielke, M. M., Melloni, M., Cox, L., Yaffe, K., Santamaria-Garcia, H., Stern, Y., & Ibanez, A. (2025) · Nature Medicine · doi:10.1038/s41591-025-03846-w · Cited by 42
Recent advances in neuroimaging of Alzheimer's disease and related dementias
Ottoy, J., Owsicki, N., Bilgel, M., Binette, A. P., Salvadó, G., Kang, M. S., Cash, D. M., Ewers, M., Joie, R. L., Wisse, L. E. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70648 · Cited by 39
Legaz, A., Altschuler, F., Gonzalez-Gomez, R., Hernández, H., Baez, S., Migeot, J., Fittipaldi, S., Medel, V., Maito, M. A., Godoy, M. E., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00781-2 · Cited by 36
Computational whole-body-exposome models for global precision brain health
Ibáñez, A. M., Duran-Aniotz, C. A., Migeot, J., Báez, S., Fittipaldi, S., Coronel‐Oliveros, C., Eyre, H. A., Udeh‐Momoh, C. T., Zetterberg, H., Alladi, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67448-3 · Cited by 31
Self-citationSerrano‐Pozo, A., Escott‐Price, V., Grinberg, L. T., Pascoal, T. A., Suárez‐Calvet, M., Dubois, B., & Sperling, R. A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00198-4 · Cited by 21
Metadata
- Authors
- McGlinchey, E., Duran-Aniotz, C., Akinyemi, R., Arshad, F., Zimmer, E. R., Cho, H., Adewale, B. A., & Ibanez, A.
- Affiliations
- University of California, San Francisco (US)
- Adolfo Ibáñez University (CL)
- Universidade Federal do Rio Grande do Sul (BR)
- University of Ibadan (NG)
- Corresponding author
- McGlinchey, Eimear
- ORCID
- Venue
- The Lancet Healthy Longevity
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 5
- Issue
- 10
- Pages
- 100616
- ISSN
- 2666-7568 (ISSN-L)
- PMC
- PMC11540104
- OpenAlex
- W4403087807
- Cited by
- 32
- References
- 163
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 2
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Update notices
- erratum (2024-11-01)
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Healthy Longevity (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Alzheimer's Association (20-725707, SG-20- 725707, AARGD-21-850670, Serra-1912-31365)
- Global Brain Health Institute
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (409066/2022-2, 312306/2021-0, 435642/2018- 9, 465671/2014‐4, 312410/2018‐2, 21/2551-0000673-0, 2014-4, 16/2551‐0000475‐7)
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (16/2551–0000475–7, 2014-4, 16/2551, 21/2551- 0000673-0)
- Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção (# 465671/2014-4)
- Instituto Serrapilheira (Serra‐1912‐31365)
- Agencia Nacional de Investigación y Desarrollo (ANID/PIA/ANILLOS ACT210096, ACT210096, FONDAP-15150012, PIA/ANILLOS ACT210096, 15150012, ID20I10152, 1210195, 1210622, 1210176, 1220995)
- National Institutes of Health (15150012)
- National Institute on Aging (R01AG057234, R01AG072547, P01AG019724, U19AG074865, R01AG075775)
- Fogarty International Center
- Fondo de Fomento al Desarrollo Científico y Tecnológico (ID20I10152)
- Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias (15150012)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- neurodegenerative diseases, biomarkers, Global South, dementia, fluid biomarkers, neuroimaging biomarkers, genetic biomarkers, plasma biomarkers, Latin America, Africa, South and East Asia, international cooperation, brain health, sociocultural stigma
- MeSH terms
- Africa, Humans, Latin America, Global Health, Biomarkers, Neurodegenerative Diseases, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomarkers of neurodegeneration across the Global South. https://app.cochat.ai/papers/10.1016/s2666-7568(24)00132-6
- The paper
- McGlinchey, E., Duran-Aniotz, C., Akinyemi, R., Arshad, F., Zimmer, E. R., Cho, H., Adewale, B. A., & Ibanez, A. (2024). Biomarkers of neurodegeneration across the Global South. The Lancet Healthy Longevity. https://doi.org/10.1016/s2666-7568(24)00132-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.